Related Experiment Video
Updated: May 23, 2026

07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Angiogenesis, lymphangiogenesis and atopic dermatitis.
Chemical Immunology and Allergy
|March 22, 2012
Summary
Vascular endothelial growth factors (VEGFs) and angiopoietins drive blood vessel changes in skin inflammation. Atopic dermatitis patients show elevated VEGF-A, linking inflammation to vascular alterations.
Area of Science:
- Dermatology
- Vascular Biology
- Immunology
Background:
- Chronic inflammatory disorders, including skin diseases, exhibit characteristic microvessel alterations.
- Vascular endothelial growth factors (VEGFs) and angiopoietins are critical regulators of blood vessel formation and remodeling.
- VEGF-A and VEGF-B promote angiogenesis, while VEGF-C and VEGF-D are key in lymphangiogenesis.
Purpose of the Study:
- To investigate the role of angiogenic and lymphangiogenic factors in the pathogenesis of atopic dermatitis (AD).
- To explore the correlation between VEGF-A levels and disease activity in AD patients.
- To understand the contribution of inflammatory cells to vascular changes in AD.
Main Methods:
- Review of existing literature on angiogenesis, lymphangiogenesis, and their role in inflammatory skin diseases.
- Analysis of studies measuring VEGF-A levels in AD skin tissue.
- Examination of the sources of angiogenic and lymphangiogenic factors within inflamed skin.
Main Results:
- Elevated levels of VEGF-A are found in the skin of atopic dermatitis patients.
- VEGF-A levels in AD skin correlate with disease severity and activity.
- Inflammatory effector cells in the skin are significant producers of various angiogenic and lymphangiogenic factors.
Conclusions:
- Vascular changes in AD are closely associated with the underlying inflammatory process.
- VEGF-A is a key factor implicated in the vascular pathology of atopic dermatitis.
- The specific role of lymphangiogenesis in AD remains an area requiring further investigation.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
